Tag: biosimilar vs originator
Biosimilar Switching: What Happens When You Change from Originator Biologic
Switching from an originator biologic to a biosimilar is safe for most patients with stable autoimmune conditions. Learn what really happens during the switch, why some people stop treatment, and how to make the transition work for you.
view morerecent posts
Cipro (ciprofloxacin) is no longer the first choice for most infections. Learn safer, equally effective alternatives for UTIs, sinus infections, and more in 2025-and when Cipro is still necessary.
Published ON: 1 DecSSRIs can cause dangerous low sodium levels, especially in older adults, leading to confusion, falls, and hospitalization. Learn who’s at risk, which antidepressants are safest, and what steps to take to prevent this hidden side effect.
Published ON: 1 DecLithium carbonate generics require strict serum level monitoring due to their narrow therapeutic index. Learn how brand switches, dosing, age, and kidney function affect safety and effectiveness in bipolar disorder treatment.
Published ON: 12 DecThe FDA issues warning letters to manufacturers who violate safety and labeling laws. These letters are the first step in enforcement that can lead to recalls, fines, or criminal charges. Learn how the agency targets non-compliant companies and what you must do to avoid serious consequences.
Published ON: 1 DecHealthcare shortages are worsening across U.S. hospitals and clinics, with nurse staffing levels at critical lows. Patient safety, access to care, and provider burnout are all under severe strain - here’s what’s really happening on the ground.
Published ON: 15 Dec